Start date : 29/11/2021
End date : 30/11/2021
European Commission,
Consumer affairs and public health, Covid-19,
- Events/Conf/Fairs
Building on the experience of the EU Task Force for Industrial Scale-up of COVID-19 vaccines and therapeutics, the European Commission continues to facilitate cooperation between actors in the EU supply chain to ensure that available therapeutics are produced in sufficient quantity as soon as possible.
On the 29 and 30 November, the European Commission is organising the Second Virtual Matchmaking Event on COVID-19 Therapeutics in partnership with the Council of European BioRegions (CEBR), the European Cluster Alliance (ECA) and the ECCP.
This event will aim to accelerate:
- the development of new and repurposed medicines for COVID-19 therapeutics
- the development of medicines used to treat the symptoms of COVID-19
- the production of disposable materials (e.g. single use systems), ingredients and raw materials required for the manufacture of medicinal products
It will also aim to mobilise the EU pharma manufacturing capacity for the production of medicines to treat and prevent COVID-19.
The target group is the entire EU COVID-19 therapeutics supply chain that have development or production facilities in the EU, such as clinical research organisations, treatment developers, funding providers and manufacturing suppliers.
